+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Transplantation Market by Product (Immunosuppressive Drugs, Tissue Products), Application (Organ Transplantation, Tissue Transplantation), End Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 195 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4986097
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Transplantation Market size was estimated at USD 28.67 billion in 2023, USD 31.09 billion in 2024, and is expected to grow at a CAGR of 8.53% to reach USD 50.86 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Transplantation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Transplantation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Transplantation Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Arthrex, Inc., Australian Red Cross Lifeblood, BioLife Solutions Inc., Dr. Franz Kohler Chemie GmbH, LifeCell International Pvt. Ltd., Mid-America Transplant, Novartis AG, Sanofi S.A., Stryker Corporation, Terumo Corporation, Teva Pharmaceutical Industries Ltd, TransMedics, Inc., Veloxis Pharmaceuticals, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Transplantation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Immunosuppressive Drugs
    • Tissue Products
  • Application
    • Organ Transplantation
    • Tissue Transplantation
  • End Use
    • Hospitals
    • Transplant Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Transplantation Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Transplantation Market?
  3. What are the technology trends and regulatory frameworks in the Transplantation Market?
  4. What is the market share of the leading vendors in the Transplantation Market?
  5. Which modes and strategic moves are suitable for entering the Transplantation Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Transplantation Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of chronic diseases
5.1.1.2. Growing awareness about organ donation and registration
5.1.1.3. Rising development of tissue banks
5.1.2. Restraints
5.1.2.1. Shortage of organ donation for treatment of organ failure
5.1.3. Opportunities
5.1.3.1. Rising technological advancement in transplant surgeries
5.1.3.2. Growing active initiatives by government and non-government organizations
5.1.4. Challenges
5.1.4.1. Growing ethical and cultural issues associated with transplantations
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Transplantation Market, by Product
6.1. Introduction
6.2. Immunosuppressive Drugs
6.3. Tissue Products
7. Transplantation Market, by Application
7.1. Introduction
7.2. Organ Transplantation
7.3. Tissue Transplantation
8. Transplantation Market, by End Use
8.1. Introduction
8.2. Hospitals
8.3. Transplant Centers
9. Americas Transplantation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Transplantation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Transplantation Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. AbbVie Inc.
13.1.2. Arthrex, Inc.
13.1.3. Australian Red Cross Lifeblood
13.1.4. BioLife Solutions Inc.
13.1.5. Dr. Franz Kohler Chemie GmbH
13.1.6. LifeCell International Pvt. Ltd.
13.1.7. Mid-America Transplant
13.1.8. Novartis AG
13.1.9. Sanofi S.A.
13.1.10. Stryker Corporation
13.1.11. Terumo Corporation
13.1.12. Teva Pharmaceutical Industries Ltd
13.1.13. TransMedics, Inc.
13.1.14. Veloxis Pharmaceuticals
13.1.15. Zimmer Biomet
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. TRANSPLANTATION MARKET RESEARCH PROCESS
FIGURE 2. TRANSPLANTATION MARKET SIZE, 2023 VS 2030
FIGURE 3. TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. TRANSPLANTATION MARKET DYNAMICS
FIGURE 7. TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. TRANSPLANTATION MARKET SIZE, BY END USE, 2023 VS 2030 (%)
FIGURE 12. TRANSPLANTATION MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. TRANSPLANTATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. TRANSPLANTATION MARKET SIZE, BY IMMUNOSUPPRESSIVE DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. TRANSPLANTATION MARKET SIZE, BY TISSUE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 9. TRANSPLANTATION MARKET SIZE, BY ORGAN TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. TRANSPLANTATION MARKET SIZE, BY TISSUE TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 12. TRANSPLANTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. TRANSPLANTATION MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 24. CANADA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. CANADA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. CANADA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 27. MEXICO TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. MEXICO TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. MEXICO TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES TRANSPLANTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 34. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 41. CHINA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. CHINA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. CHINA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 44. INDIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. INDIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. INDIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 47. INDONESIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. INDONESIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 50. JAPAN TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. JAPAN TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. JAPAN TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 53. MALAYSIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. MALAYSIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 56. PHILIPPINES TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. PHILIPPINES TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 59. SINGAPORE TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. SINGAPORE TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 62. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 65. TAIWAN TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. TAIWAN TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 68. THAILAND TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. THAILAND TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. THAILAND TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 71. VIETNAM TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. VIETNAM TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. DENMARK TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. DENMARK TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. DENMARK TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 81. EGYPT TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. EGYPT TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. EGYPT TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 84. FINLAND TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. FINLAND TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. FINLAND TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 87. FRANCE TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. FRANCE TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. FRANCE TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 90. GERMANY TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. GERMANY TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. GERMANY TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 93. ISRAEL TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. ISRAEL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 96. ITALY TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. ITALY TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ITALY TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 99. NETHERLANDS TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. NETHERLANDS TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 102. NIGERIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. NIGERIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 105. NORWAY TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. NORWAY TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. NORWAY TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 108. POLAND TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. POLAND TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. POLAND TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 111. QATAR TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. QATAR TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. QATAR TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 117. SAUDI ARABIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 120. SOUTH AFRICA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 123. SPAIN TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. SPAIN TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SPAIN TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 126. SWEDEN TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. SWEDEN TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 129. SWITZERLAND TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. SWITZERLAND TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 132. TURKEY TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. TURKEY TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. TURKEY TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 141. TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 142. TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 143. TRANSPLANTATION MARKET LICENSE & PRICING

Companies Mentioned

  • AbbVie Inc.
  • Arthrex, Inc.
  • Australian Red Cross Lifeblood
  • BioLife Solutions Inc.
  • Dr. Franz Kohler Chemie GmbH
  • LifeCell International Pvt. Ltd.
  • Mid-America Transplant
  • Novartis AG
  • Sanofi S.A.
  • Stryker Corporation
  • Terumo Corporation
  • Teva Pharmaceutical Industries Ltd
  • TransMedics, Inc.
  • Veloxis Pharmaceuticals
  • Zimmer Biomet

Methodology

Loading
LOADING...

Table Information